A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed

Trial end date:
2004-05-01

Target enrollment:

Participant gender:

A dose ranging study to evaluate the safety, tolerability and efficacy of arformoterol (given once or twice a day) in subjects with COPD.

Phase 2

Sunovion

Formoterol Fumarate
Pharmaceutical Solutions